Newron Pharmaceuticals S.p.A.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With UK’s Alchemab On A

The past year has seen an increase in investment in biopharma companies following a couple of lean years, but the sector is not fully out of the woods yet. However, most industry leaders see funding

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Kaken Obtains Aadi’s Fyarro, Comm

Newron Pharmaceuticals S.p.A. ’s evenamide bested placebo as an add-on to antipsychotic drugs in schizophrenia patients with inadequate response to an antipsychotic medication alone in the Phase II/II